Texas Mesothelioma 05/07/2012 : Texas has one of the highest rates of mesothelioma victims in the nation per capita. Mesotheliomaoccurs at a high rate in Texas due to the types of industry that exist and have existed in Texas for many decades. Ship Yard Workers, Military Veterans, Constructions Workers and workers for other specific industries are far more likely to be exposed to asbestos than the national average. Given that Texas has numerous military bases and ship yards these two industries along account for a great number of asbestos exposure victims that later develop asbestosis or mesothelioma cancer. The building boom that went on for decades around Texas created numerous construction jobs for Texans unfortunately, construction workers are among the most likely to be exposed to Asbestos. If you have been exposed to asbestos and developed asbestosis or Mesothelioma please contact us today and we will arrange a free consultation with a mesothelioma lawyer about your potential mesothelioma lawsuit. If you have had a loved one pass away from Mesothelioma or asbestosis you may be able to file a mesothelioma lawsuit for the loss of your loved one. Contact us today to get more free information.
 

1-800-611-7080

 

Mesothelioma

Mesothelioma and Asbesosis can only be caused by exposure to asbestos. Asbestos is a naturally occurring substance that has been used in the United States and around the world in construction products, auto motive products, as an insulator, in ship building and for many other purposes. Numerous schools in Texas and around the nation were built using asbestos products for one purpose or another. This wide spread use of asbestos has lead to a large number of Texas residents as well as others in the United States being exposed to asbestos. It can take decades for Mesothelioma or asbestosis to develop once an individual has been exposed to asbestos. The relatives of a person who has been exposed to asbestos can also become exposed and later develop mesothelioma or asbestosis as a result of secondary exposure from the clothing of their family member that worked around products made with asbestos. Mesothelioma is a form of cancer and at this time there is no cure. Treatments are being developed to help extend the lives of those who have Mesothelioma however, no actual cure for Mesothelioma has been developed to date.

Mesothelioma Lawsuit

If you or a loved one has been exposed to asbestos and later developed Mesothelioma then you are aware of the emotional as well as financial burdens caused by Mesothelioma. Your only recourse to recover your medical expenses as well as monetary damages suffered due to Mesothelioma is to file a Mesothelioma Lawsuit. Contact us today and we will arrange a free consultation with a Mesothelioma Lawyer about your potential Mesothelioma Lawsuit. As with any lawsuit, there is a time limit for filing a Mesothelioma Lawsuit. Do not hesitate to call us immediately for more free information and to arrange a consultation with a Mesothelioma Lawyer who can advise you of your legal rights and file a Mesothelioma Lawsuit on your behalf.
 

1-800-611-7080

 

Texas Mesothelioma Lawsuit

Many Texans have been exposed to asbestos on their jobs working in the oil industry, ship yards, as auto mechanics, school teachers people who have served in the military, as well as many other professions. Even the family members of people who have been exposed to asbestos often are exposed themselves as asbestos can cling to clothing and be brought into the home where other family members become exposed. Exposure to asbestos is the only cause of Mesothelioma and Asbestosis. Lung cancer and other diseases can also be the result of exposure to asbestos. If you or a family member has been exposed to asbestos and been diagnosed with Mesothelioma, Asbestosis or another asbestos related disease, please contact us immediately. We will arrange a free consultation with an Mesothelioma Lawyer that can talk to you about your potential mesothelioma lawsuit. There is a time limit for filing any lawsuit including a mesothelioma lawsuit. Mesothelioma Lawyer is the only person qualified to help you determine if you have a mesothelioma case. Contact us today.
 

1-800-611-7080

 

Texas Mesothelioma Lawyer

Many people mistakenly believe that if the company that exposed them to asbestos is no longer in business then they can not file a mesothelioma lawsuit because the company they would file against is no longer in business. The fact of the matter is that their are numerous mesothelioma trusts that have been set up to pay claims for mesothelioma and asbestosis victims that were exposed to asbestos by companies than are no longer in business. A Mesothelioma Attorney can often collect money damages for the victims of mesothelioma and asbestosis, or their families, even if the company that exposed them to asbestos is not longer in business.

Texas Mesothelioma Attorney

If your immediate family member passed away due to Mesothelioma or another disease caused by exposure to Asbestos, in many cases the family will have the right to file a lawsuit for the wrongful death of their family member. As with any lawsuit, there are time limits for family members of those who have passed away as a result mesothelioma and asbestosis to file their Mesothelioma Lawsuit. A Mesothelioma Lawyer can help guide you through the process of determining if you still have time to file a mesothelioma lawsuit or other asbestos lawsuit due to the wrongful death of their loved one. Do not delay. Contact us today.

Texas Mesothelioma Attorneys

What if the victim was exposed to Asbestos on more than one job? Often people who work in professions where they are likely to be exposed to asbestos will be exposed to asbestos more than once while working for different employers. Mesothelioma Attorneys may be able to pursue lawsuits against any and all employers that exposed you or your loved one to asbestosis. Every employer that exposed you to asbestos put you at risk and it may not be possible or necessary to prove which employer exposed you to asbestos that lead to your contracting Mesothelioma, Asbestosis or another asbestos related disease. In many of these cases every employer that exposed your or your loved one to asbestos may be liable for the medical bills, pain and suffering and even the loss of life that can result from these deadly diseases that result from exposure to asbestos.

Texas Mesothelioma Lawyers

The only way to know for sure if you have a mesothelioma lawsuit or other asbestos related lawsuit is to talk to a Mesothelioma Lawyer, which you can do for free. Mesothelioma Lawyers do not charge your for the consultation nor do you pay legal fees unless the Mesothelioma Lawyer wins your case. The Mesothelioma Lawyer fees are paid from the money the Mesothelioma Lawyer collects for you. If no money is collected, you owe nothing. You have everything to gain and nothing to lose by contacting
 

1-800-611-7080

 

Pradaxa Lawsuit News - 2/29/2012: Did you take Pradaxa? Please contact us today if you took Pradaxa and later experienced harmful side effects. We will connect you with a lawyer that is experienced in complex litigation that may be able to help you recover monetary damages.

Pradaxa Lawsuit: Intracerebral hemorrhage (ICH) accounts for 10-15% of all strokes. Primary ICH occurs when small intracranial vessels are damaged by chronic hypertension (HTN) or cerebral amyloid angiopathy (CAA), and accounts for 78-88% of all ICH. The incidence of ICH worldwide ranges from 10 to 20 cases per 100 000 population and increases with age. Certain populations, in particular, the Japanese and those of Afro-Caribbean descent, have a heightened incidence of 50-55 per 100 000 that may reflect a higher prevalence of HTN and/or decreased access to healthcare. The incidence of hemorrhage increases exponentially with age and is higher in men than in women. Neurologic deficits from ICH reflect the location of the initial bleeding and associated edema. In addition, seizures, vomiting, headache, and diminished level of consciousness are common presenting symptoms. A depressed level of alertness on initial evaluation occurs infrequently in acute ischemic stroke (AIS) but is seen in approximately 50% of patients with ICH.

Pradaxa Lawsuit: Spontaneous, or non-traumatic, ICH has a much poorer outcome than AIS.1 There is a 62% mortality rate by 1 year, and only about 20% of survivors are living independently by 6 months. About half of the deaths due to ICH over the first 30 days will occur within the first 2 days, largely from cerebral herniation. Later, mortality is more commonly due to medical complications, such as aspiration pneumonia or venous thromboembolism. By far the most important modifiable risk factor for spontaneous ICH is HTN. Primary hypertensive hemorrhage results from the rupture of small penetrating arteries originating in the anterior, middle (i.e., articulateness), and posterior cerebral (i.e., thalamostriate) arteries and the pons (i.e., paramedian perforators) (1.3). HTN causes vessel rupture at or near the bifurcation of affected vessels, where degeneration of components of the arterial wall (media and smooth muscle) are identified. The annual risk of recurrent hemorrhage is 2% without antihypertensive treatment.

Pradaxa Lawsuit: Cerebral amyloid angiopathy. This multiloculated, oparietal region (left)lobar lesion seen on non-contrast head CT scan (A), started in the right front and by the next day (right), developed extensive intraventricular involvement, subfalcine herniation with right-to-left shift, and a subarachnoid component. The hyperdense finding in the frontal horns is an intraventricular catheter (arrowhead). Macropathology: lobar hematoma, with adjacent edema (B). Note the midline mass effect on and compression of the adjacent lateral ventricle (arrows). Micropathology: amyloid angiopathy, demonstrated by deposits within the vessel wall of an acellular, eosinophilic material (hematoxylin and eosin (H&E) stain) (C, 40x; D, 100x; arrows). The amyloid material exhibits a fluorescent green birefringence under polarized light (thioflavin S stain, 100x) (E). Illicit drug use and coagulopathic disorder are associated with an increased risk of ICH. Over-the-counter stimulants, particularly if taken in excessive quantities, may predispose to ICH (case study 1). A large case-control study associated phenylpropanolamine use with ICH in young patients.Up to 70% of patients with primary ICH develop some measurable amount of lesion expansion over the initial few hours.Hematoma growth is an independent determinant of both mortality and functional outcome after ICH.

Pradaxa Lawsuit

Pradaxa Lawsuit

: By far the most important modifiable risk factor for spontaneous ICH is HTN.Primary hypertensive hemorrhage results from the rupture of small penetrating arteries originating in the anterior, middle (i.e., lenticulostriate), and posterior cerebral (i.e., thalamostriate) arteries and the pons (i.e., paramedian perforators). HTN causes vessel rupture at or near the bifurcation of affected vessels, where degeneration of components of the arterial wall (media and smooth muscle) are identified. The annual risk of recurrent hemorrhage is 2% without antihypertensive treatment. A hematoma incites local edema and neuronal damage in the adjacent brain parenchyma. This edema typically increases in size over an interval as long as 3 weeks following the initial bleeding, with the greatest growth rate over the first 2 days. Thrombin within the hematoma plays a central role in promoting perihematomal edema. Hemoglobin and its products, heme and iron, are potent mitochondrial toxins, thereby increasing cell death.

Pradaxa Lawsuit: Hemorrhage may dissect from the brain parenchyma into the adjacent ventricular space, carrying a poor prognosis, Hemorrhage may also be isolated to the intraventricular space,and lesions can expand substantially by rupturing into the ventricular system. Ventricular involvement may cause obstructive hydrocephalus and can result in long-term cognitive impairment.

Pradaxa Lawsuit: Significant clinical deterioration associated with PH is known as ‘symptomatic hemorrhage, an important outcome measure in acute stroke treatment. One common definition for symptomatic hemorrhage is a clinical deterioration of >4 points on the National Institutes of Health Stroke Scale (NIHSS) associated with hemorrhage seen on CT scan. Various predictors for symptomatic hemorrhage include hyperglycemia, concur­rent heparin use, the timing of successful recanalization, a history of diabetes and cardiac disease, leukoariosis, early signs of infarct on CT scans, and elevated pretreatment mean blood pressure. Neurosurgical evacuation typically is not a helpful treatment for symptomatic hemorrhage, because the lesion is frequently large and multifocal. Extra-ischemic hematomas are: located remotely from the initial ischemic stroke lesion; may be isolated or multifocal, with or without mass effect (1.17);23 and associated with concurrent coagulopathy and previously occult vasculopathies, such as CAA, microhemorrhages, or hypertensive vasculopathy. In the NINDS (National Institute of Neurological Disorders and Stroke) trial of IV t-PA for AIS, the incidence of extra-ischemic cerebral hematomas was 1.3%.

Pradaxa Lawsuit

Pradaxa Lawsuit

: Venous occlusive intracranial disease is associated with oral contraceptive use the immediate post-partum period, and a wide range of hypercoagulable medical conditions. Significant cerebral venous thrombosis involves one or more of the major venous sinuses and typically results in parenchymal hemorrhage. By definition, the territories of the ischemic and hemorrhagic lesions are in a venous, rather than arterial, distribution. Involvement of the deep venous system (case study 3) carries a much worse prognosis than if only the superficial sinuses and/or cortical veins (1.20) are involved. Magnetic resonance venography (MRV) is commonly used to identify major venous sinus occlusions.

Pradaxa Lawsuit: The single mandated indication for neurosurgical decompression is cerebellar hemorrhage. Early craniotomy, prior to brainstem compression, is critical. The best surgical candidates are patients with an initial GCS <14 and hematoma volume >40 ml, while those with higher GCS and smaller lesions are likely to have a good outcome with conservative, non-surgical management. Neurosurgical evacuation of clot in primary hemispheric ICH has had mixed results in randomized and non­randomized clinical trials. The leading study, I-STICH (International Surgical Trial in Intracerebral Haemorrhage), identified neutral outcomes for early evacuation. Nonetheless, a role for neurosurgical decompression to reduce clot size may exist in highly selected patients, particularly younger patients (e.g., <60 years old) who have cerebellar hemorrhage, treated with neurosurgery. Head CT scan shows a large, primary ICH based in the cerebellar vermis, causing effacement of the basal cisterns around the pons and early obstructive hydrocephalus, with markedly enlarged temporal horns (arrows) (A). The patient underwent emergent craniotomy over the next few hours, and subsequent CT scan the following day (B) shows recovery of basal cisterns, reduction in ventricular size, and a pocket of air in the left cerebellar hemisphere (arrowhead), with some edema in the left middle cerebellar peduncle. Note the craniotomy defect from the left suboccipital approach.

Pradaxa Lawsuit: Less invasive surgical interventions, such as catheter-based clot aspiration or thrombolysis, are being studied. Intraventricular ICH may contribute to elevated intra­cranial pressure (ICP) by causing obstructive hydrocephalus. The amount of ventricular blood to cause hydrocephalus need not be great (1.22). In this setting, external drainage of cerebrospinal fluid via ventricular catheter may be indicated to reduce ICP.

Pradaxa Lawsuit

Pradaxa Lawsuit:

Commonly considered agents: beta-blockers (labetalol, esmo­lol), calcium channel blockers (nicardipine), angiotensin con­verting enzyme (ACE) inhibitors (enalapril), and hydralazine. Other agents such as nitroprusside are effective as second-line options but carry the risk of significant vasodilation.Mass effect causing significant elevation of ICP, with the risk for cerebral herniation syndromes, may be managed emergently with osmotic agents, such as mannitol and/or hypertonic saline, and hyperventilation.However, these approaches have never been formally studied in clinical trials. Seizures occur in 10% of patients with primary ICH, usually at onset or within the initial 24 hours, and reflect cortical involvement of the lesion.

Pradaxa Lawsuit:Anticonvulsant agents are empirically recommended for patients with significant hematomas in peripheral territories in the cerebral hemispheres. The appropriate duration of anticonvulsant use has not been established. For patients who are seizure- free, guidelines suggest discontinuation of the anti-epileptic drug after the first month post-hemorrhage. Neurointensivist management of ICH in an intensive care unit (ICU) setting may improve patient outcomes.

Pradaxa Lawsuit: News and Information from related Sources

Pradaxa Lawsuit: Various clinical trials, including SHEP (Systolic Hypertension in the Elderly Program)and PROGRESS (Perindopril Protection Against Recurrent Stroke Study), have documented the critical role of antihypertensive agents in both primary and secondary stroke prevention of ICH. The JNC-7 report (Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure) provides an extensive overview of the role of HTN in stroke risk, specific drug classes, lifestyle modifications, and target blood pressures. In general, lower blood pressures are associated with a proportional reduction of recurrent stroke and stroke mortality.

Pradaxa Lawsuit

Pradaxa Lawsuit

: By far the most important modifiable risk factor for spontaneous ICH is HTN.Primary hypertensive hemorrhage results from the rupture of small penetrating arteries originating in the anterior, middle (i.e., lenticulostriate), and posterior cerebral (i.e., thalamostriate) arteries and the pons (i.e., paramedian perforators). HTN causes vessel rupture at or near the bifurcation of affected vessels, where degeneration of components of the arterial wall (media and smooth muscle) are identified. The annual risk of recurrent hemorrhage is 2% without antihypertensive treatment. A hematoma incites local edema and neuronal damage in the adjacent brain parenchyma. This edema typically increases in size over an interval as long as 3 weeks following the initial bleeding, with the greatest growth rate over the first 2 days. Thrombin within the hematoma plays a central role in promoting perihematomal edema. Hemoglobin and its products, heme and iron, are potent mitochondrial toxins, thereby increasing cell death.

Hemorrhage may dissect from the brain parenchyma into the adjacent ventricular space, carrying a poor prognosis, Hemorrhage may also be isolated to the intraventricular space,and lesions can expand substantially by rupturing into the ventricular system. Ventricular involvement may cause obstructive hydrocephalus and can result in long-term cognitive impairment.

Significant clinical deterioration associated with PH is known as ‘symptomatic hemorrhage, an important outcome measure in acute stroke treatment. One common definition for symptomatic hemorrhage is a clinical deterioration of >4 points on the National Institutes of Health Stroke Scale (NIHSS) associated with hemorrhage seen on CT scan. Various predictors for symptomatic hemorrhage include hyperglycemia, concur­rent heparin use, the timing of successful recanalization, a history of diabetes and cardiac disease, leukoariosis, early signs of infarct on CT scans, and elevated pretreatment mean blood pressure. Neurosurgical evacuation typically is not a helpful treatment for symptomatic hemorrhage, because the lesion is frequently large and multifocal. Extra-ischemic hematomas are: located remotely from the initial ischemic stroke lesion; may be isolated or multifocal, with or without mass effect (1.17);23 and associated with concurrent coagulopathy and previously occult vasculopathies, such as CAA, microhemorrhages, or hypertensive vasculopathy. In the NINDS (National Institute of Neurological Disorders and Stroke) trial of IV t-PA for AIS, the incidence of extra-ischemic cerebral hematomas was 1.3%.

Pradaxa Lawsuit

The holiday season is in the air which means children everywhere are anxiously awaiting the latest new toys. Parents of children with cerebral palsy (CP) have a slightly different feat to tackle and must shop strategically in order to choose the best toy that will be fun and also aid in their child’s development. Websites such as Cerebral Palsy Toys and Play Aids and Astra Toy have lists to help parents pick out the best toys for their children. We have gathered some guidelines to help parents choose the best gifts that will surely thrill your child!

1.     Cater to your child’s capabilities: It’s important to think about the abilities of your child and avoid choosing a toy that is so complicated that it will frustrate your child or too simple and will not provide stimulation.

2.    Try to improve on certain skills: If there is an area such as motor skills or hand-eye coordination that your child struggles with, try to find toys that will help improve on these skills.

3.     Avoid trendy toys: Although those glitzy toy commercials may seem like they would be any child’s dream, keep your child’s needs in mind. These types of toys might be overwhelming to a child with CP. Instead, go for the more classic toys which can be just as much fun.

4.     Allow your child to choose: Children who are able to choose which toys they want are likely to be more excited to play with them.

5.    Take safety precautions: Be sure to thoroughly evaluate toys before you purchase them to check that they are the correct size and won’t pose a choking risk.

6.     Do some research: The internet provides an ample amount of resources that enable parents to research a toy before deciding to make that final purchase. AblePlay.com includes product reviews from experts which rate how appropriate each toy is based on various disabilities.

Below is a list of toys that fit into the above guidelines:

0-12 MONTHS:

· Super-Deluxe 3-D Lights & Music Activity Gym

· Skwish Classic (by Manhattan Toy)

· Symphony Tower

· Ball Party Light & Sound Ball (by Tomy)

· Curiosity Cube (Early Years, Interventional Playthings)

1-3 YEARS:

· The Original Rollercoaster (by Anatex)

· Pound and Play (by International Playthings)

· Tube With a View (by Small World Toys)

· Galt Pop Up Toy

· Busy Box (by Small World Toys)

· Musical Shape Sorter (by Small World Toys)

· Busy Vehicles Sound Puzzle (by Small World Toys)

3 YEARS and UP:

· Little Partners Learning Tower

· Nobbie Gertie Ball (by Small World Toys)

· Pathfinder – Explore the Trails of Pathfinder (by Anatex)

· Sound Tracks (Dragonfly Toys)

· Play Sports 30” Funball (by Small World Toys)

Many of these toys can be found at various major retailers throughout the U.S., both online and in stores. We hope this guide helps you find the perfect gift for your child this holiday season.

http://www.seedol.com

Mesothelioma Cancer

What is mesothelioma?

Malignant Mesothelioma is a rare form of cancer that is found in the lining of the chest and lung (the pleura), the abdomen (the peritoneum), or the saclike space around the heart (the pericardium). Although it is rare, mesothelioma is a very serious disease that is often at an advanced stage when the diagnosis is made. In the United States an estimated 2000 to 4000 new

cases of Mesothelioma are diagnosed each year. Approximately three fourths of these cases start in

the chest cavity and are called pleural mesotheliomas. Another 10% to 20% begin in the abdomen and are called peritoneal mesotheliomas. Lastly, those that start in the lining around the heart are called pericardial mesotheliomas, but these are extremely rare.

Are there different types of Mesothelioma?

Mesothelioma is divided into three main types, based on what the cancer cells look like under the microscope. The most frequent type is epithelioid. About 50% to 70% of mesotheliomas are of this type. It usually has the best prognosis or outlook of the three. The second type is called the sarcomatoid, which makes up about 7% to 20% of mesotheliomas. It has a very unpredictable pattern or nature. The last type, called mixed or biphasic, is a combination of the first two types

and makes up about 20% to 35% of mesotheliomas. Although there are different types of mesothelioma,

the treatment options, at this time, are essentially the

same for all types.

What is the pleura Mesothelioam?

The pleura is a sheetlike lining formed by rectangular cells called mesothehal cells, and is usually not more than a few layers thick. There are two pleuras in the chest; the parietal pleura lines the inside of the chest wall like wallpaper, covering not only the inside of the ribs but also the diaphragm (the muscle in between the chest and abdominal cavities that moves with breathing)

and pericardium. The normal parietal pleura is no more than 2 to 3 mm thick, where the normal visceral pleura is fused to the lung and is about 1 mm thick.

The visceral pleura is a separate pleura that covers the lung and is much more difficult to remove without harming the lung. The pleura filters fluid back and

forth from the chest to the circulation in the normal human, but it is expendable if it becomes diseased

To recieve updates on Mesothelioma Cancer, subsribe to our RSS news feed.

http://www.seedol.com

Birth Defects Lawyers: An antirheumatic drug, ], l,3-trimethyl-/-phenylbiuret, produced strain-specific ventricular septal defects of the heart in rats following high oral doses (Yamakita et al., 1989). The remainder of the teratogens in this group are salts or esters of salicylic acid and are generally used as antirheumatic agents. One member of the group, widely used as a flavoring agent (oil of wmtergreen), methyl salicylate, had teratogenic capability in all four species tested (Warkany and Takacs, 1959; Szabo and Kang, 1969; Overman and AVhite, 1983). Conflicting results occurred in the rat, however, as high doses applied dermally in another study (Infurna et al., 1990) elicited no developmental toxicity. Lack of dermal absorption in the latter instance may account for the difference. 3-PyridylmethyIsaticylate induced skeletal defects in a few mouse fetuses (Cekanova et al., 1974).

Salicylamide treatment produced a high incidence of minor anomalies in hamsters (LaPointe and Harvey, 1964), but apparently was not teratogenic in mice (Wright, 1967) or rats (Koshakji and Schulert, 1973). Congenital defects, primarily of the skeleton, were resultant in both mouse (Larsson et al., 1963) and rat offspring (Warkany and Takacs, 1959) from maternal treatment with sodium salicylate. Among other species, cleft lip-palate, and eye, limb, and tail defects were produced in ferrets (Gulamhusein et al., 1980), while rabbits and guinea pigs suffered no teratogenic effects from sodium salicylale (Mosher, 1938; Jackson, 1948). For more informaiton on Birth Defects Lawyer subscribe to RSS feed.

http://www.seedol.com

 Page 1 of 50  1  2  3  4  5 » ...  Last »